Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization.
Tumor-associated macrophages are known to influence cancer progression by modulation of immune function, angiogenesis, and cell metastasis, however, little is known about the chemokine signaling networks that regulate this process. Utilizing CT26 colon cancer cells and RAW 264.7 macrophages as a model cellular system, we demonstrate that treatment of CT26 cells with RAW 264.7 conditioned medium induces cell migration, invasion and metastasis. Inflammatory gene microarray analysis indicated CT26-stimulated RAW 264.7 macrophages upregulate SDF-1alpha and VEGF, and that these cytokines contribute to CT26 migration in vitro. RAW 264.7 macrophages also showed a robust chemotactic response towards CT26-derived chemokines. In particular, microarray analysis and functional testing revealed CSF-1 as the major chemoattractant for RAW 264.7 macrophages. Interestingly, in the chick CAM model of cancer progression, RAW 264.7 macrophages localized specifically to the tumor periphery where they were found to increase CT26 tumor growth, microvascular density, vascular disruption, and lung metastasis, suggesting these cells home to actively invading areas of the tumor, but not the hypoxic core of the tumor mass. In support of these findings, hypoxic conditions down regulated CSF-1 production in several tumor cell lines and decreased RAW 264.7 macrophage migration in vitro. Together our findings suggest a model where normoxic tumor cells release CSF-1 to recruit macrophages to the tumor periphery where they secrete motility and angiogenic factors that facilitate tumor cell invasion and metastasis.
Green
Chad E
CE
Department of Pathology and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America.
Liu
Tiffany
T
Montel
Valerie
V
Hsiao
Gene
G
Lester
Robin D
RD
Subramaniam
Shankar
S
Gonias
Steven L
SL
Klemke
Richard L
RL
D000818:Animals; D002460:Cell Line; D002465:Cell Movement; D002630:Chemotactic Factors / Q000378:metabolism*; D002642:Chick Embryo; D017077:Culture Media, Conditioned; D020869:Gene Expression Profiling; D008264:Macrophages / Q000166:cytology / Q000378:metabolism*; D051379:Mice; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology; D009389:Neovascularization, Pathologic; D020411:Oligonucleotide Array Sequence Analysis; D016133:Polymerase Chain Reaction; D015398:Signal Transduction
D002630:Chemotactic Factors; D017077:Culture Media, Conditioned
J Cell Biol. 2007 Jul 30;178(3):425-36
17664334
Mol Cancer Res. 2007 Jan;5(1):21-33
17259344
Br J Cancer. 1999 Feb;79(5-6):991-5
10070902
Carcinogenesis. 2004 Aug;25(8):1543-9
15044327
Am J Pathol. 2000 Aug;157(2):411-21
10934146
J Cell Biol. 2000 Apr 3;149(1):223-36
10747099
J Cell Biol. 2004 Oct 25;167(2):223-9
15504909
Am J Pathol. 1994 Oct;145(4):856-67
7943176
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W627-32
15980550
Bioinformatics. 2004 Nov 22;20(17):3108-27
15217816
J Exp Med. 2001 Mar 19;193(6):727-40
11257139
Cancer Res. 2005 Jul 1;65(13):5578-87
15994930
Annu Rev Pathol. 2006;1:119-50
18039110
Lancet. 1993 Jul 17;342(8864):148-9
8101258
Nature. 2005 Jul 28;436(7050):518-24
16049480
Nat Rev Cancer. 2003 May;3(5):362-74
12724734
Am J Physiol Cell Physiol. 2007 Mar;292(3):C987-95
16943240
J Pathol. 2002 Feb;196(2):204-12
11793372
Cell. 2006 Jan 27;124(2):263-6
16439202
Nat Rev Cancer. 2006 Jul;6(7):506-20
16794634
Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17406-11
17954920
J Leukoc Biol. 1995 May;57(5):747-51
7539028
Cancer Lett. 2008 Aug 28;267(2):204-15
18448242
Cancer Res. 2005 Jun 15;65(12):5278-83
15958574
Nat Rev Genet. 2006 Jan;7(1):55-65
16369572
Cancer Res. 2006 Jan 15;66(2):605-12
16423985
Trends Immunol. 2002 Nov;23(11):549-55
12401408
J Cell Biol. 1997 Apr 21;137(2):481-92
9128257
J Immunol. 2006 Apr 15;176(8):5023-32
16585599
Histochem Cell Biol. 2008 Dec;130(6):1119-30
19005674
J Mammary Gland Biol Neoplasia. 2002 Apr;7(2):177-89
12463738
Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):31-6
11134512
Am J Pathol. 2005 May;166(5):1565-79
15855655
Blood. 2004 Oct 15;104(8):2224-34
15231578
Mol Oncol. 2007 Dec;1(3):288-302
18509509
Anticancer Res. 2004 Sep-Oct;24(5C):3335-42
15515429
Nat Rev Cancer. 2004 Jan;4(1):71-8
14708027
Cancer Res. 2004 Oct 1;64(19):7022-9
15466195
Int J Cancer. 2005 Dec 10;117(5):701-8
16106399
J Cell Biol. 1998 Feb 23;140(4):961-72
9472046
J Pathol. 2000 Oct;192(2):150-8
11004690
Br J Cancer. 1994 Aug;70(2):289-92
7519867